| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | -72.4% |
| Cost of Revenue | $23K | +53.3% |
| Gross Profit | -$15K | -207.1% |
| R&D Expense | $240K | -29.2% |
| SG&A Expense | $16.7M | +1398.1% |
| Operating Income | -$17.1M | -835.3% |
| Pre-tax Income | -$15.1M | -274.4% |
| Net Income | -$15.1M | -274.4% |
| EPS (Basic) | -$0.03 | -188.9% |
| EPS (Diluted) | -$0.03 | -188.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $408K | +416.5% |
| Inventory | $50K | +117.4% |
| Current Assets | $571K | +335.9% |
| Total Assets | $21.7M | +5544.9% |
| Current Liabilities | $7.9M | +374.0% |
| Total Liabilities | $8.8M | +94.3% |
| Stockholders' Equity | $12.9M | +413.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$606K | +22.8% |
| Investing Cash Flow | -$80K | +0.0% |
| Financing Cash Flow | $935K | +30.0% |